Abstract: Ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorde4rs characterized by aberrant erbB family PTK activity.
Type:
Grant
Filed:
June 28, 2001
Date of Patent:
January 2, 2007
Assignee:
SmithKline Beecham (Cork) Limited
Inventors:
Michael Scott McClure, Martin Howard Osterhout, Frank Roschangar, Mark Joseph Sacchetti